Your browser doesn't support javascript.
loading
Pharmacist-Delivered Smoking Cessation Program in Community Pharmacy (The FINE Program) in Japan-The Development of a Training Course and a Feasibility Study.
Onda, Mitsuko; Kuwanoe, Takashi; Hashimoto, Atsunori; Horiguchi, Michiko; Domichi, Masayuki; Sakane, Naoki.
  • Onda M; Department of Social and Administrative Pharmacy, 34776Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.
  • Kuwanoe T; Cocokara Fine Healthcare Inc, Yokohama, Kanagawa, Japan.
  • Hashimoto A; Cocokara Fine Healthcare Inc, Yokohama, Kanagawa, Japan.
  • Horiguchi M; Cocokara Fine Healthcare Inc, Yokohama, Kanagawa, Japan.
  • Domichi M; Division of Preventive Medicine, 37048National Hospital Organization, Kyoto Medical Center, Clinical Research Institute, Kyoto, Japan.
  • Sakane N; Division of Preventive Medicine, 37048National Hospital Organization, Kyoto Medical Center, Clinical Research Institute, Kyoto, Japan.
J Pharm Pract ; 34(4): 625-630, 2021 Aug.
Article en En | MEDLINE | ID: mdl-31835966
ABSTRACT

AIM:

Although smoking cessation support has been recommended as a routine component of pharmacists'duties, there is limited evidence of smoking cessation being achieved successfully in community pharmacy. The aim of this study was to develop a new smoking cessation program for use in the community pharmacy setting and investigate its feasibility.

METHODS:

A feasibility study (the Family pharmacist's Intervention for Nicotine Elimination [FINE] program) was conducted using 8 pharmacists at 2 community pharmacies in Japan. The pharmacists recruited as subjects smokers 20 or more years of age who were taking medications such as antidiabetes drugs. The patients completed questionnaires assessing their smoking status, and the pharmacists provided them with smoking cessation support services. Participating patients met with the pharmacists or talked to them on the phone 5 times at 2- to 4-week intervals and received personalized and structured brief smoking cessation advice. The primary outcome was continuous abstinence determined by Micro Smokerlyzer carbon monoxide monitor at 3 months.

RESULTS:

Of 5306 patients, 2296 patients were screened and the rate of smoking was found to be 12.7%. Five smoking patients received the FINE program from pharmacists who had received training. One of the 5 succeeded in quitting smoking after 3 months.

CONCLUSIONS:

This is the first study to target Japanese smoking patients in community pharmacies with a brief structured intervention. The results tentatively support the feasibility of the FINE program. Further research including a randomized controlled trial is required to confirm the effectiveness of the FINE program.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacias / Cese del Hábito de Fumar / Servicios Comunitarios de Farmacia Tipo de estudio: Clinical_trials / Qualitative_research Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacias / Cese del Hábito de Fumar / Servicios Comunitarios de Farmacia Tipo de estudio: Clinical_trials / Qualitative_research Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article